Anti-SAMD1 functional antibody

Anti-SAMD1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SAMD1/SAMD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1519-Ab-1/ GM-Tg-hg-SE1519-Ab-2Anti-Human SAMD1 monoclonal antibodyHuman
GM-Tg-rg-SE1519-Ab-1/ GM-Tg-rg-SE1519-Ab-2Anti-Rat SAMD1 monoclonal antibodyRat
GM-Tg-mg-SE1519-Ab-1/ GM-Tg-mg-SE1519-Ab-2Anti-Mouse SAMD1 monoclonal antibodyMouse
GM-Tg-cynog-SE1519-Ab-1/ GM-Tg-cynog-SE1519-Ab-2Anti-Cynomolgus/ Rhesus macaque SAMD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1519-Ab-1/ GM-Tg-felg-SE1519-Ab-2Anti-Feline SAMD1 monoclonal antibodyFeline
GM-Tg-cang-SE1519-Ab-1/ GM-Tg-cang-SE1519-Ab-2Anti-Canine SAMD1 monoclonal antibodyCanine
GM-Tg-bovg-SE1519-Ab-1/ GM-Tg-bovg-SE1519-Ab-2Anti-Bovine SAMD1 monoclonal antibodyBovine
GM-Tg-equg-SE1519-Ab-1/ GM-Tg-equg-SE1519-Ab-2Anti-Equine SAMD1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg

Product Description

Catalog No.GM-Tg-hg-SE1519-Ab-1/ GM-Tg-hg-SE1519-Ab-2; GM-Tg-rg-SE1519-Ab-1/ GM-Tg-rg-SE1519-Ab-2;
GM-Tg-mg-SE1519-Ab-1/ GM-Tg-mg-SE1519-Ab-2; GM-Tg-cynog-SE1519-Ab-1/ GM-Tg-cynog-SE1519-Ab-2;
GM-Tg-felg-SE1519-Ab-1/ GM-Tg-felg-SE1519-Ab-2; GM-Tg-cang-SE1519-Ab-1/ GM-Tg-cang-SE1519-Ab-2;
GM-Tg-bovg-SE1519-Ab-1/ GM-Tg-bovg-SE1519-Ab-2; GM-Tg-equg-SE1519-Ab-1/ GM-Tg-equg-SE1519-Ab-2
Products NameAnti-SAMD1 monoclonal antibody
Target NameSAMD1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
Products descriptionPre-made anti-SAMD1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


    Data / case study

    Click to get more Data / Case study about the product.

    Associated products

    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1519-Ag-1Recombinant multi-species SAMD1 protein

    Target information

    Target IDGM-SE1519
    Target NameSAMD1
    Gene ID90378,666704,102550189,106994647,100688148,101097047,112447336,100146281
    Gene Symbol and Synonymsatherin,RGD1305094,SAMD1
    Uniprot AccessionQ6SPF0
    Uniprot Entry NameSAMD1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Gene EnsemblENSG00000141858
    Target ClassificationN/A

    The target: SAMD1, gene name: SAMD1, also named as . Annotation category: suggests misassembly.

    About Gmab


    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.